Device
i-scan
i-scan is a medical device with 6 clinical trials. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 6 completed trials
Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
33%(2 trials)
Phase Distribution
Ph not_applicable
5
83%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution5 total trials
N/ANon-phased studies
5(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
6 of 6 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Completed(6)
Detailed Status
Completed6
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A5 (100.0%)
Trials by Status
completed6100%
Recent Activity
0 active trials
Showing 5 of 6
completednot_applicable
Artificial Intelligence and Dysplasia Detection in Ulcerative Colitis (CUDISIA Study)
NCT05171634
completednot_applicable
i-Scan for the Detection of Helicobacter Pylori
NCT02385045
completed
The Non-Optical Resect and Discard Study (NORD)
NCT04032912
completednot_applicable
I-scan for Adenoma Detection
NCT02811419
completednot_applicable
I-Scan a Novel Endoscopic Tool for the Macroscopic Identification of Mucosal Lesions
NCT03298776
Clinical Trials (6)
Showing 6 of 6 trials
NCT05171634Not Applicable
Artificial Intelligence and Dysplasia Detection in Ulcerative Colitis (CUDISIA Study)
NCT02385045Not Applicable
i-Scan for the Detection of Helicobacter Pylori
NCT04032912
The Non-Optical Resect and Discard Study (NORD)
NCT02811419Not Applicable
I-scan for Adenoma Detection
NCT03298776Not Applicable
I-Scan a Novel Endoscopic Tool for the Macroscopic Identification of Mucosal Lesions
NCT01381991Not Applicable
The Efficacy of i-Scan for Detecting Reflux Esophagitis
All 6 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 6